Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
by Richardson, Paul G. (Author)
, Sonneveld, Pieter (Author)
, Schuster, Michael W. (Author)
, Stadtmauer, Edward A. (Author)
, Facon, Thierry (Author)
, Harousseau, Jean-Luc (Author)
, Ben-Yehuda, Dina (Author)
, Lonial, Sagar (Author)
, Goldschmidt, Hartmut (Author)
, Reece, Donna (Author)
, Bladé, Joan (Author)
, Boccadoro, Mario (Author)
, Cavenagh, Jamie D. (Author)
, Boral, Anthony L. (Author)
, Esseltine, Dixie-Lee (Author)
, Wen, Patrick Y. (Author)
, Amato, Anthony A. (Author)
, Anderson, Kenneth C. (Author)
, San Miguel, Jesus (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource